NYU LANGONE HEALTH
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1841-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.nyulangone.org
Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-06-18
- Last Posted Date
- 2012-11-09
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00005048
- Locations
- ๐บ๐ธ
Kaplan Cancer Center, New York, New York, United States
๐บ๐ธMount Sinai Medical Center, NY, New York, New York, United States
Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2004-06-08
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00005050
- Locations
- ๐บ๐ธ
Kaplan Cancer Center, New York, New York, United States
Combination Chemotherapy in Treating Patients With Advanced Cancer
- Conditions
- Unspecified Adult Solid Tumor, Protocol SpecificLeukemiaLymphomaSarcoma
- First Posted Date
- 2004-05-25
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00004105
- Locations
- ๐บ๐ธ
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States
Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer
- Conditions
- Ovarian Cancer
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2012-11-09
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00002671
- Locations
- ๐บ๐ธ
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States
๐บ๐ธNew York Presbyterian Hospital - Cornell Campus, New York, New York, United States
๐บ๐ธOverlook Hospital, Summit, New Jersey, United States
Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke
- Conditions
- Lung Cancer
- First Posted Date
- 2004-04-28
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00005883
Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
- Conditions
- Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-04-27
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 44
- Registration Number
- NCT00003144
- Locations
- ๐บ๐ธ
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States
Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2004-04-21
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00010010
- Locations
- ๐บ๐ธ
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States
Chemotherapy in Treating Patients With Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2004-04-20
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00012129
- Locations
- ๐บ๐ธ
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States
Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma
- Conditions
- Malignant Mesothelioma
- First Posted Date
- 2004-04-15
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 30
- Registration Number
- NCT00004033
- Locations
- ๐บ๐ธ
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
๐บ๐ธNYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States
PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma
- Conditions
- LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-04-12
- Last Posted Date
- 2012-11-09
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00004002
- Locations
- ๐บ๐ธ
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
๐บ๐ธDana-Farber Cancer Institute, Boston, Massachusetts, United States
๐บ๐ธBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States